$3.55
al cierre: Oct 23 EDT
$3.60
0.051.41%
Pre-comercialización: 7:47 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Indaptus Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 11
Estimación de BPA
$-4.170
Estimación de ingresos trimestrales
–
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
–
Analice el historial de beneficios de Indaptus Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
INDP | Indaptus Therapeutics | -$8.96 | -$4.17 | — | — | $0.00 | — | — | — | 11/11/2025 | |
INDP | Indaptus Therapeutics | -$13.16 | — | -$9.09 | — | $0.00 | — | $0.00 | — | 08/13/2025 | |
INDP | Indaptus Therapeutics | -$12.60 | -$11.48 | -$8.96 | 21.95% | $0.00 | — | $0.00 | — | 05/14/2025 | |
INDP | Indaptus Therapeutics | -$12.88 | -$11.48 | -$10.64 | 7.32% | $0.00 | — | $0.00 | — | 03/13/2025 | |
INDP | Indaptus Therapeutics | -$13.16 | -$11.76 | -$8.96 | 23.81% | $0.00 | — | $0.00 | — | 11/12/2024 | |
INDP | Indaptus Therapeutics | -$10.92 | -$15.12 | -$13.16 | 12.96% | $0.00 | — | $0.00 | — | 08/12/2024 | |
INDP | Indaptus Therapeutics | -$14.28 | -$12.32 | -$12.60 | -2.27% | $0.00 | — | $0.00 | — | 05/08/2024 | |
INDP | Indaptus Therapeutics | -$12.32 | -$15.12 | -$12.88 | 14.81% | $0.00 | — | $0.00 | — | 03/13/2024 | |
INDP | Indaptus Therapeutics | -$11.76 | -$15.40 | -$13.16 | 14.55% | $0.00 | — | $0.00 | — | 11/06/2023 | |
INDP | Indaptus Therapeutics | -$12.88 | -$16.24 | -$10.92 | 32.76% | $0.00 | — | $0.00 | — | 08/14/2023 | |
INDP | Indaptus Therapeutics | -$11.48 | -$16.52 | -$14.28 | 13.56% | $0.00 | — | $0.00 | — | 05/11/2023 | |
INDP | Indaptus Therapeutics | -$6.16 | -$14.56 | -$12.32 | 15.38% | $0.00 | — | $0.00 | — | 03/17/2023 | |
INDP | Indaptus Therapeutics | -$22.68 | -$14.84 | -$11.76 | 20.75% | $0.00 | — | $0.00 | — | 11/10/2022 | |
INDP | Indaptus Therapeutics | -$154.84 | -$13.44 | -$12.88 | 4.17% | $0.00 | — | $0.00 | — | 08/08/2022 | |
INDP | Indaptus Therapeutics | -$8.68 | -$23.24 | -$11.48 | 50.60% | $0.00 | — | $0.00 | — | 05/12/2022 | |
INDP | Indaptus Therapeutics | -$20.44 | -$25.20 | -$6.16 | 75.56% | $0.00 | — | $0.00 | — | 03/21/2022 | |
INDP | Indaptus Therapeutics | -$22.12 | -$16.80 | -$22.68 | -35.00% | $0.00 | — | $0.00 | — | 11/15/2021 | |
INDP | Indaptus Therapeutics | — | — | -$154.84 | — | — | — | $0.00 | — | 08/16/2021 | |
INDP | Indaptus Therapeutics | — | — | -$26.88 | — | — | — | $0.00 | — | 05/17/2021 | |
INDP | Indaptus Therapeutics | — | — | -$20.44 | — | — | — | $0.00 | — | 03/16/2021 | |
INDP | Indaptus Therapeutics | — | — | -$26.60 | — | — | — | $0.00 | — | 11/05/2020 |
Indaptus Therapeutics (INDP) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q1 | 2025-05-14 | $-8.96 | $-11.48 | 21.9 % |
| Q4 | 2025-03-13 | $-10.64 | $-11.48 | 7.32 % |
| Q3 | 2024-11-12 | $-8.96 | $-11.76 | 23.8 % |
| Q2 | 2024-08-12 | $-13.16 | $-15.12 | 13.0 % |
Indaptus Therapeutics (INDP) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
PREGUNTAS FRECUENTES
¿Cuándo Indaptus Therapeutics (NASDAQ:INDP) publicará los resultados?
Está previsto que Indaptus Therapeutics (INDP) presente resultados el noviembre 11, 2025. Los últimos resultados se publicaron el agosto 13, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Indaptus Therapeutics (NASDAQ:INDP)?
El BPA real fue de $-9.09, que no alcanzó la estimación de $0.00.
¿Cuáles fueron los ingresos de Indaptus Therapeutics (NASDAQ:INDP)?
Los ingresos reales fueron $0K, que alcanzó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.